DSGN
Design TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
DSGN vs peer average
95/100
DSGN vs. peer average (A vs. D)
Grade spread
B 1 · D 4 · F 6
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Loose same-sector small-cap biopharma comparator; useful mainly for development-stage and financing-risk context, not a direct indication peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
DSGN
Design Therapeutics
ABUS
Arbutus Biopharma
Grade
A
B
Momentum
17
23
Value
41
55
Sentiment
92
67
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ABUS
DSGN / ABUS
Grade Position
Above peers
DSGN vs. peer average (A vs. D)
95/100
Momentum
17
ABUSValue
41
ABUSSentiment
92
DSGNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs DSGN
ABUS is the first peer returned for this comparison set.